RecruitingPhase 3NCT07505836
Rare condition
Meningococcal meningitis
6
studies recruiting now
as of 7 Sept 2026
208
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
1 Apr 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT07505823
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months
RecruitingPhase 3NCT07505810
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months
RecruitingNCT04664569
National Bacterial Meningitis Study in Children and Newborns
RecruitingPhase 4NCT06832514
Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 6 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Meningococcal meningitis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Meningococcal meningitis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
4 approved treatments and 3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Neisseria Meningitidis Factor H Binding Protein (Neisseria meningitidis factor h binding protein component of bexsero)Approved: Neisseria Meningitidis Neisserial Heparin Binding Antigen (Neisseria meningitidis neisserial heparin binding antigen component of bexsero)Approved: Neisseria Meningitidis Outer Membrane Vesicles (Neisseria meningitidis outer membrane vesicles component of bexsero)Approved: Neisseria Meningitidis Adhesin A (Neisseria meningitidis adhesin a component of bexsero)
Phase 3Diphtheria Toxoid (Diphtheria toxoid component of hexacima)
Phase 3Tetanus Toxoid (Equilis te)
Phase 2/3Neisseria Meningitidis Oligosaccharide Conjugated To Corynebacterium Diphtheriae Crm197 (Menveo)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).